John W. Davies

Nessuna posizione attualmente

63 anni

Consumer Services

Health Technology

Commercial Services

Profilo

John W.
Davies worked as the Global Head-Silico Lead Discovery at Novartis Institutes for Biomedical Research, Inc. from 2012 to 2017.
He then worked as the Chief Technology Officer at Kaleido Biosciences, Inc. from 2017 to 2019.
Prior to his professional career, he earned an undergraduate degree from the University of East London and a doctorate from University College London.

Precedenti posizioni note di John W. Davies

Società	Posizione	Fine
KALEIDO BIOSCIENCES, INC.	Direttore Tecnico/Scientifico/R&S	01/01/2019
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/01/2017

Vedi nel dettaglio l'esperienza di John W. Davies

Formazione di John W. Davies

University of East London	Undergraduate Degree
University College London	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John W. Davies

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
KALEIDO BIOSCIENCES, INC.	Health Technology

Aziende private	1
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.	Commercial Services